Cited by

• Neuronal CD200 Signaling Is Protective in the Acute Phase of Ischemic Stroke.

  Al Mamun A, Ngwa C, Qi S, Honarpisheh P, Datar S, Sharmeen R, Xu Y, McCullough LD, Liu F. Al Mamun A, et al. Stroke. 2021 Oct;52(10):3362-3373. doi: 10.1161/STROKEAHA.120.032374. Epub 2021 Aug 6. Stroke. 2021. PMID: 34353112 Free PMC article.
• Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.

  Tilson HA, Baker TG, Chamberlain JH. Tilson HA, et al. Psychopharmacologia. 1975 Nov 21;44(3):229-39. doi: 10.1007/BF00428899. Psychopharmacologia. 1975. PMID: 1208759
• Myeloid cell IRF4 signaling protects neonatal brains from hypoxic ischemic encephalopathy.

  Al Mamun A, Yu H, Mirza MA, Romana S, McCullough LD, Liu F. Al Mamun A, et al. Neurochem Int. 2019 Jul;127:148-157. doi: 10.1016/j.neuint.2018.12.014. Epub 2018 Dec 23. Neurochem Int. 2019. PMID: 30586599 Free PMC article.
• IL-34 exacerbates pathogenic features of Alzheimer's disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice.

  Ho A, Ngala B, Yamada C, Garcia C, Duarte C, Akkaoui J, Ciolac D, Nusbaum A, Kochen W, Efremova D, Groppa S, Nathanson L, Bissel S, Oblak A, Kacena MA, Movila A. Ho A, et al. Biomed Pharmacother. 2023 Oct;166:115435. doi: 10.1016/j.biopha.2023.115435. Epub 2023 Sep 4. Biomed Pharmacother. 2023. PMID: 37666180 Free PMC article.
• The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration.

  Ortí-Casañ N, Boerema AS, Köpke K, Ebskamp A, Keijser J, Zhang Y, Chen T, Dolga AM, Broersen K, Fischer R, Pfizenmaier K, Kontermann RE, Eisel ULM. Ortí-Casañ N, et al. Sci Rep. 2023 Jun 30;13(1):10622. doi: 10.1038/s41598-023-36846-2. Sci Rep. 2023. PMID: 37391534 Free PMC article.